KHK has been linked to MASLD progression; it is increased in MASH mouse models13,14 and patients,14 and in preclinical studies, inhibition of KHK was effective in mitigating MASH steatosis.15 The gene discussed is KHK; the disease is metabolic dysfunction-associated steatotic liver disease.